Nuvonis is a biotech company providing innovative cell banks for vaccine and vector production that will dramatically speed up your development. Our experienced team provides technical support for virus production processes and vaccine strain improvement. Nuvonis Vero Cell Banks (R&D and GMP) Nuvonis provides “ready to use” GMP Master and GMP Working Cell Banks that were produced under serum and animal-free media conditions. The cell banks are immediately available for GMP manufacturing and are fully characterized including tumorigenicity testing at the end of production level. Nuvonis Avian Cell Banks We have developed a continuous avian cell line from primary quail cells. Nuvonis Avian Cell Banks are available both for adherent growth and growth in suspension. Importantly, avian cell lines can be used to replace Chicken Embryo Fibroblasts (CEF) or cultivation in embryonated hen’s eggs. Process Development Services The Nuvonis team is highly experienced in the development and optimization of up- and downstream vaccine production processes. We are offering a proprietary and efficient virus purification process for the generation of high purity vaccines.